Marie‐Pierre Pruniaux

880 total citations
21 papers, 618 citations indexed

About

Marie‐Pierre Pruniaux is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Marie‐Pierre Pruniaux has authored 21 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Surgery. Recurrent topics in Marie‐Pierre Pruniaux's work include Phosphodiesterase function and regulation (7 papers), Receptor Mechanisms and Signaling (6 papers) and Mast cells and histamine (5 papers). Marie‐Pierre Pruniaux is often cited by papers focused on Phosphodiesterase function and regulation (7 papers), Receptor Mechanisms and Signaling (6 papers) and Mast cells and histamine (5 papers). Marie‐Pierre Pruniaux collaborates with scholars based in France, United States and United Kingdom. Marie‐Pierre Pruniaux's co-authors include Vincent Lagente, Claude Bertrand, Etienne Guillot, Jean‐Louis Junien, Anne‐Marie Galzin, Corinne Martin‐Chouly, Claire Jacob, Michel Fink, Éric Chevalier and Fabien Schmidlin and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and International Journal of Molecular Sciences.

In The Last Decade

Marie‐Pierre Pruniaux

21 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie‐Pierre Pruniaux France 15 305 191 190 146 80 21 618
M A Giembycz United Kingdom 12 254 0.8× 127 0.7× 294 1.5× 123 0.8× 138 1.7× 14 627
Maria Rosa Accomazzo Italy 14 218 0.7× 73 0.4× 182 1.0× 80 0.5× 32 0.4× 23 455
Cesaria Prontera Italy 10 169 0.6× 213 1.1× 46 0.2× 75 0.5× 47 0.6× 10 677
Anita K. Salyers United States 16 202 0.7× 309 1.6× 247 1.3× 97 0.7× 29 0.4× 21 942
Tetyana V. Pedchenko United States 14 256 0.8× 39 0.2× 156 0.8× 102 0.7× 33 0.4× 14 560
Iskandar Yakubov United States 9 261 0.9× 54 0.3× 145 0.8× 68 0.5× 31 0.4× 13 759
Sidath Katugampola United Kingdom 11 197 0.6× 286 1.5× 187 1.0× 51 0.3× 39 0.5× 17 791
Rosemary Murray United States 9 301 1.0× 120 0.6× 122 0.6× 45 0.3× 42 0.5× 19 542
Pingfang Song United States 15 559 1.8× 98 0.5× 145 0.8× 41 0.3× 107 1.3× 29 831
E B Haddad United Kingdom 17 247 0.8× 107 0.6× 371 2.0× 142 1.0× 253 3.2× 20 789

Countries citing papers authored by Marie‐Pierre Pruniaux

Since Specialization
Citations

This map shows the geographic impact of Marie‐Pierre Pruniaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Pierre Pruniaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Pierre Pruniaux more than expected).

Fields of papers citing papers by Marie‐Pierre Pruniaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Pierre Pruniaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Pierre Pruniaux. The network helps show where Marie‐Pierre Pruniaux may publish in the future.

Co-authorship network of co-authors of Marie‐Pierre Pruniaux

This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Pierre Pruniaux. A scholar is included among the top collaborators of Marie‐Pierre Pruniaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Pierre Pruniaux. Marie‐Pierre Pruniaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chemello, Kévin, Sandra Beeské, Thi Thu Trang Tran, et al.. (2020). Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab. JACC Basic to Translational Science. 5(6). 549–557. 19 indexed citations
2.
Beauverger, Philippe, Marie‐Laure Ozoux, Alain Corbier, et al.. (2019). Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy. Cardiovascular Research. 116(2). 329–338. 36 indexed citations
3.
Briand, Pascale, Alain Corbier, Bruno Poirier, et al.. (2019). 3071Peptidomimetic targeting of CavBeta2 improves contractility in models of senescence- or genetically (MYBPC3 KI)-induced heart failure. European Heart Journal. 40(Supplement_1). 1 indexed citations
4.
Jeziorowska, Dorota, Vincent Fontaine, Charlène Jouve, et al.. (2017). Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols. International Journal of Molecular Sciences. 18(6). 1173–1173. 24 indexed citations
5.
Hurst, W. Jeffrey, Etienne Guillot, Werngard Czechtizky, et al.. (2013). Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part II). Bioorganic & Medicinal Chemistry Letters. 23(11). 3421–3426. 5 indexed citations
6.
7.
Griebel, Guy, Philippe Pichat, Marie‐Pierre Pruniaux, et al.. (2012). SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents. Pharmacology Biochemistry and Behavior. 102(2). 203–214. 41 indexed citations
8.
Pang, Zhen, Nancy Wu, Weiguang Zhao, et al.. (2011). The Central Cannabinoid CB1 Receptor Is Required for Diet‐Induced Obesity and Rimonabant's Antiobesity Effects in Mice. Obesity. 19(10). 1923–1934. 33 indexed citations
9.
Migrenne, Stéphanie, Amélie Lacombe, Marie‐Pierre Pruniaux, et al.. (2009). Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 296(4). R929–R935. 32 indexed citations
10.
Bail, Jean-Christophe Le, et al.. (2009). Beneficial effect of a chronic treatment with rimonabant on pancreatic function and β-cell morphology in Zucker Fatty rats. European Journal of Pharmacology. 616(1-3). 314–320. 25 indexed citations
11.
Pruniaux, Marie‐Pierre, et al.. (2009). Relationship between phosphodiesterase type 4 inhibition and anti‐inflammatory activity of CI‐1044 in rat airways. Fundamental and Clinical Pharmacology. 24(1). 73–82. 2 indexed citations
12.
Jelsing, Jacob, Anne‐Marie Galzin, Etienne Guillot, et al.. (2008). Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2. Brain Research Bulletin. 78(4-5). 202–210. 19 indexed citations
13.
Fink, Michel, et al.. (2006). Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD. Pulmonary Pharmacology & Therapeutics. 20(1). 60–68. 25 indexed citations
14.
Chevalier, Éric, Jeff Stock, Timothy S. Fisher, et al.. (2005). Cutting Edge: Chemoattractant Receptor-Homologous Molecule Expressed on TH2 Cells Plays a Restricting Role on IL-5 Production and Eosinophil Recruitment. The Journal of Immunology. 175(4). 2056–2060. 69 indexed citations
15.
Martin‐Chouly, Corinne, et al.. (2004). Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors. Life Sciences. 75(7). 823–840. 47 indexed citations
16.
Martin‐Chouly, Corinne, Graziella Brinchault, Claude Bertrand, et al.. (2004). The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-α production in whole blood from COPD patients. Pulmonary Pharmacology & Therapeutics. 18(1). 49–54. 30 indexed citations
17.
Pruniaux, Marie‐Pierre, et al.. (2004). Recent Advances in PDE4 Inhibitors as Immunoregulators and Antiinflammatory Drugs. 1(1). 293–345. 13 indexed citations
18.
Pruniaux, Marie‐Pierre, et al.. (2002). Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs. Current Pharmaceutical Design. 8(14). 1255–1296. 102 indexed citations
19.
Auclair, Eric, et al.. (2000). Synthesis and structure–activity relationships of 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indoles: novel PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(1). 35–38. 16 indexed citations
20.
Lagente, Vincent, et al.. (1995). Modulation of Cytokine-Induced Eosinophil Infiltration by Phosphodiesterase Inhibitors. American Journal of Respiratory and Critical Care Medicine. 151(6). 1720–1724. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M A Giembycz Breakdown of academic impact, for papers by Maria Rosa Accomazzo Breakdown of academic impact, for papers by Cesaria Prontera Breakdown of academic impact, for papers by Anita K. Salyers Breakdown of academic impact, for papers by Tetyana V. Pedchenko Breakdown of academic impact, for papers by Iskandar Yakubov Breakdown of academic impact, for papers by Sidath Katugampola Breakdown of academic impact, for papers by Rosemary Murray Breakdown of academic impact, for papers by Pingfang Song Breakdown of academic impact, for papers by E B Haddad
Rankless by CCL
2026